366 related articles for article (PubMed ID: 15585354)
1. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
Freyberger A; Schmuck G
Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
[TBL] [Abstract][Full Text] [Related]
2. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
4. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
[TBL] [Abstract][Full Text] [Related]
6. The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability.
Witters H; Freyberger A; Smits K; Vangenechten C; Lofink W; Weimer M; Bremer S; Ahr PH; Berckmans P
Reprod Toxicol; 2010 Aug; 30(1):60-72. PubMed ID: 20362049
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
8. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals.
Rogers JM; Denison MS
In Vitr Mol Toxicol; 2000; 13(1):67-82. PubMed ID: 10900408
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
[TBL] [Abstract][Full Text] [Related]
10. Food-associated estrogenic compounds induce estrogen receptor-mediated luciferase gene expression in transgenic male mice.
Ter Veld MG; Zawadzka E; van den Berg JH; van der Saag PT; Rietjens IM; Murk AJ
Chem Biol Interact; 2008 Jul; 174(2):126-33. PubMed ID: 18501883
[TBL] [Abstract][Full Text] [Related]
11. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta.
Fujimoto N; Kitamura S
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):53-9. PubMed ID: 15026083
[TBL] [Abstract][Full Text] [Related]
12. Screening of endocrine disrupting chemicals with MELN cells, an ER-transactivation assay combined with cytotoxicity assessment.
Berckmans P; Leppens H; Vangenechten C; Witters H
Toxicol In Vitro; 2007 Oct; 21(7):1262-7. PubMed ID: 17572059
[TBL] [Abstract][Full Text] [Related]
13. Endocrine toxicology--contributions of in vitro methods to the 3R concept.
Freyberger A; Scholz G
ALTEX; 2004; 21 Suppl 3():20-7. PubMed ID: 15057405
[TBL] [Abstract][Full Text] [Related]
14. A stable fish reporter cell line to study estrogen receptor transactivation by environmental (xeno)estrogens.
Cosnefroy A; Brion F; Guillet B; Laville N; Porcher JM; Balaguer P; Aït-Aïssa S
Toxicol In Vitro; 2009 Dec; 23(8):1450-4. PubMed ID: 19591918
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta.
Papoutsi Z; Kassi E; Tsiapara A; Fokialakis N; Chrousos GP; Moutsatsou P
J Agric Food Chem; 2005 Oct; 53(20):7715-20. PubMed ID: 16190622
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
17. [Establishment and its application of a reporter-based screening model for discovering new ligands of estrogen receptor alpha subtypes].
Sun Z; Lu QJ; Wen LQ; Guo SM; Chen YY; Liu WJ
Yao Xue Xue Bao; 2000 Oct; 35(10):747-51. PubMed ID: 11372440
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the promoter-specific estrogenic potency of the phytoestrogens genistein, daidzein and coumestrol.
Zierau O; Kolba S; Olff S; Vollmer G; Diel P
Planta Med; 2006 Feb; 72(2):184-6. PubMed ID: 16491457
[TBL] [Abstract][Full Text] [Related]
19. Estrogenic in vitro assay on mouse embryonic Leydig cells.
La Sala G; Farini D; De Felici M
Int J Dev Biol; 2010; 54(4):717-22. PubMed ID: 20209442
[TBL] [Abstract][Full Text] [Related]
20. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay.
Breinholt V; Larsen JC
Chem Res Toxicol; 1998 Jun; 11(6):622-9. PubMed ID: 9625730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]